Drs. Addala, Chou, Gloyn, Lal spoke to The SugarScience on flexing innovations in genetics, insulin bioengineering, & diabetes tech to advance health equity in diabetes diagnosis & management

Written by Diana L Sung

Drs. Ananta Addala, Danny Chou, Anna Gloyn and Rayhan Lal spoke to The SugarScience on flexing innovations in genetics, insulin bioengineering, and diabetes technology to advance health equity in diabetes diagnosis and management.

Diana L Sung
Previous

A podcast about diabetes and genes - Dr. Anna Gloyn – the gene detective
Next

Why precision medicine leads to better diabetes care, a comprehensive report with contributions from Jessie Wong, SDRC Affinity leaders Anna Gloyn and Korey Hood, and SDRC member Jennifer Ikle